Fri28 Beta cell: Immune interactions Start time: 11:00 am End time: 12:00 pm Boisdale Chair: Matt Johnson, Exeter Susan Wong, Cardiff Roberto Mallone, Paris, France James Pearson, Cardiff The 'menage a trois' between beta cells, T cells and interferons Start time: 11:00 am End time: 11:30 am Roberto Mallone, Paris, France Time of day influences protective immune responses altering susceptibility to type 1 diabetes Start time: 11:30 am End time: 12:00 pm James Pearson, Cardiff
The 'menage a trois' between beta cells, T cells and interferons Start time: 11:00 am End time: 11:30 am Roberto Mallone, Paris, France
Time of day influences protective immune responses altering susceptibility to type 1 diabetes Start time: 11:30 am End time: 12:00 pm James Pearson, Cardiff
Fri28 New priorities for type 1 diabetes research Start time: 11:00 am End time: 12:00 pm M1 Chair: John Petrie, Glasgow Emma Wilmot, Nottingham Christine Newman, Galway, Ireland Oratile Kgosidialwa, Cork, Ireland Jinty Moffett, Kinguissie How we developed the priorities Start time: 11:00 am End time: 11:15 am Christine Newman, Galway, Ireland Presenting the top 10 Start time: 11:15 am End time: 11:35 am Oratile Kgosidialwa, Cork, Ireland A lived experience commentary Start time: 11:35 am End time: 11:45 am Jinty Moffett, Kinguissie Questions Start time: 11:45 am End time: 12:00 pm
How we developed the priorities Start time: 11:00 am End time: 11:15 am Christine Newman, Galway, Ireland
Fri28 Pregnancy Start time: 11:00 am End time: 12:00 pm Carron Chair: Caroline Byrne, London Cathy Jones, Leicester
Fri28 Sex hormones, beta cells and diabetes genetics Start time: 11:00 am End time: 12:00 pm Dochart Chair: Ahmad Al-Mrabeh, Edinburgh Astrid Hauge-Evans, Roehampton
Fri28 Awards Ceremony Start time: 12:10 pm End time: 12:20 pm Hall 5 Chair: Colette Marshall, Diabetes UK
Fri28 Dorothy Hodgkin Lecture Start time: 12:20 pm End time: 01:00 pm Hall 5 Chair: Andrew Hattersley, Exeter Inês Barroso, Exeter Diabetes: From genetic discovery to impact for patients Start time: 12:20 pm End time: 1:00 pm Inês Barroso, Exeter
Diabetes: From genetic discovery to impact for patients Start time: 12:20 pm End time: 1:00 pm Inês Barroso, Exeter
Fri28 Facilitated posters: Basic science 2 Start time: 12:20 pm End time: 01:00 pm Poster theatre (Exhibition Hall)
Fri28 An update on ABCD activity Start time: 01:05 pm End time: 01:55 pm M1 Chair: Ketan Dhatariya, Norwich Ketan Dhatariya, Norwich Bob Ryder, Birmingham Emma Wilmot, Derby An update on overall ABCD activity Start time: 1:05 pm End time: 1:30 pm Ketan Dhatariya, Norwich An update on ABCD audit activity Start time: 1:30 pm End time: 1:55 pm Bob Ryder, Birmingham Emma Wilmot, Derby
An update on ABCD audit activity Start time: 1:30 pm End time: 1:55 pm Bob Ryder, Birmingham Emma Wilmot, Derby
Fri28 Diabetic retinopathy and new treatments for type 1 and type 2 diabetes: What do I need to know? Start time: 02:15 pm End time: 03:15 pm Lomond Chair: Ian Lawrence, Leicester Anwen Jones, Wales Peter Scanlon, Gloucestershire Garry Tan, Oxford New and old treatments, rapid HbA1c control and early worsening of retinopathy Start time: 2:15 pm End time: 2:55 pm Peter Scanlon, Gloucestershire Garry Tan, Oxford Questions Start time: 2:55 pm End time: 3:15 pm
New and old treatments, rapid HbA1c control and early worsening of retinopathy Start time: 2:15 pm End time: 2:55 pm Peter Scanlon, Gloucestershire Garry Tan, Oxford
Fri28 Medico legal matters in diabetes care Start time: 02:15 pm End time: 03:15 pm Alsh Chair: Raju Ahluwalia, London Reena Patel, Leicester Victoria Colclough Samuel Seidu, Leicester Case discussions Start time: 2:15 pm End time: 3:05 pm Victoria Colclough Samuel Seidu, Leicester Questions Start time: 3:05 pm End time: 3:15 pm Victoria Colclough Samuel Seidu, Leicester
Fri28 Technology use in people with type 2 diabetes and other specific types of diabetes: How might technology benefit those with type 2 diabetes Start time: 02:15 pm End time: 03:45 pm M1 Chair: Tom Crabtree, Derby Emma Wilmot, Derby Deepa Patel, London Hood Thabit, Manchester Charlotte Boughton, Cambridge Technology use in people with type 2 diabetes Start time: 2:15 pm End time: 2:35 pm Emma Wilmot, Derby Growing the evidence base to inform future diabetes care and technology guidelines: The experience of a diabetes specialist nurse in using CGM in people living with type 2 diabetes and renal disease Start time: 2:35 pm End time: 2:55 pm Deepa Patel, London Use of diabetes related technology in the non-critical care settings Start time: 2:55 pm End time: 3:15 pm Hood Thabit, Manchester Closed loop in cystic fibrosis related diabetes Start time: 3:15 pm End time: 3:45 pm Charlotte Boughton, Cambridge
Technology use in people with type 2 diabetes Start time: 2:15 pm End time: 2:35 pm Emma Wilmot, Derby
Growing the evidence base to inform future diabetes care and technology guidelines: The experience of a diabetes specialist nurse in using CGM in people living with type 2 diabetes and renal disease Start time: 2:35 pm End time: 2:55 pm Deepa Patel, London
Use of diabetes related technology in the non-critical care settings Start time: 2:55 pm End time: 3:15 pm Hood Thabit, Manchester
Closed loop in cystic fibrosis related diabetes Start time: 3:15 pm End time: 3:45 pm Charlotte Boughton, Cambridge
Fri28 Diabetes UK rising stars Start time: 02:15 pm End time: 03:15 pm Carron Chair: Claire Meek, Leicester Naveed Sattar, Glasgow Charlotte Moffett, Ulster Judith Lechner, Belfast Rachel Jennings, Manchester George Mcilroy, Aberdeen Benoit Hastoy, Oxford Female fertility in diabetes Start time: 2:15 pm End time: 2:27 pm Dawood Khan, Ulster The role of the APC/EPCR pathway in vasoregeneration and its implications for diabetic retinopathy Start time: 2:27 pm End time: 2:39 pm Judith Lechner, Belfast Is type 2 diabetes risk mediated through pancreas development? Start time: 2:39 pm End time: 2:51 pm Rachel Jennings, Manchester Exploiting gene therapy to discover treatments for type 2 diabetes Start time: 2:51 pm End time: 3:03 pm George Mcilroy, Aberdeen Using cellular models to unravel dysregulation of insulin secretion in type 2 diabetes Start time: 3:03 pm End time: 3:15 pm Benoit Hastoy, Oxford
The role of the APC/EPCR pathway in vasoregeneration and its implications for diabetic retinopathy Start time: 2:27 pm End time: 2:39 pm Judith Lechner, Belfast
Is type 2 diabetes risk mediated through pancreas development? Start time: 2:39 pm End time: 2:51 pm Rachel Jennings, Manchester
Exploiting gene therapy to discover treatments for type 2 diabetes Start time: 2:51 pm End time: 3:03 pm George Mcilroy, Aberdeen
Using cellular models to unravel dysregulation of insulin secretion in type 2 diabetes Start time: 3:03 pm End time: 3:15 pm Benoit Hastoy, Oxford
Fri28 In conversation with Partha Kar: Improving type1 diabetes and eating disorder care: Expert panel and open questions Start time: 02:15 pm End time: 03:15 pm Hall 5 Partha Kar, Portsmouth Sarah Alicea, London Carla Figueiredo, Dorset Chris Garrett, London Jessica Parkin, Yorkshire Interviewer Start time: 2:15 pm End time: 3:15 pm Partha Kar, Portsmouth Panel Start time: 2:15 pm End time: 3:15 pm Sarah Alicea, London Carla Figueiredo, Dorset Chris Garrett, London Jessica Parkin, Yorkshire
Panel Start time: 2:15 pm End time: 3:15 pm Sarah Alicea, London Carla Figueiredo, Dorset Chris Garrett, London Jessica Parkin, Yorkshire
